Bard Loses Appeal, Set to Pay $2 Million in Mesh Verdict
by Ty Armstrong
Last Updated on June 26, 2017
C.R. Bard, Inc. lost its appeal of a jury’s $2 million verdict in Fourth Circuit appellate court on Thursday. The court found that the medical device manufacturer was, in fact, responsible for the injuries the plaintiff suffered after she was implanted with the company’s transvaginal mesh device. In the appeal, Bard claimed that the district court wrongly excluded evidence regarding the FDA’s approval of its product. The court decided that the approval of the product did not adequately represent its safety, only how well it matched something already on the market.
Camp Lejeune
Camp Lejeune residents may soon have the opportunity to claim compensation for harm suffered from contaminated water.
Read more here: Camp Lejeune Lawsuit Claims
Stay Current
Sign Up For
Our Newsletter
New cases and investigations, settlement deadlines, and news straight to your inbox.
Before commenting, please review our comment policy.